These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18035683)

  • 21. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.
    Zatloukal K; Stumptner C; Fuchsbichler A; Heid H; Schnoelzer M; Kenner L; Kleinert R; Prinz M; Aguzzi A; Denk H
    Am J Pathol; 2002 Jan; 160(1):255-63. PubMed ID: 11786419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
    J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice.
    Yuan QX; Nagao Y; Gaal K; Hu B; French SW
    Exp Mol Pathol; 1998 Oct; 65(2):87-103. PubMed ID: 9828150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?
    Denk H; Stumptner C; Fuchsbichler A; Müller T; Farr G; Müller W; Terracciano L; Zatloukal K
    J Pathol; 2006 Apr; 208(5):653-61. PubMed ID: 16477590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation.
    Hirano K; Roth J; Zuber C; Ziak M
    Histochem Cell Biol; 2002 Jan; 117(1):41-53. PubMed ID: 11819096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-fat diet triggers Mallory-Denk body formation through misfolding and crosslinking of excess keratin 8.
    Kucukoglu O; Guldiken N; Chen Y; Usachov V; El-Heliebi A; Haybaeck J; Denk H; Trautwein C; Strnad P
    Hepatology; 2014 Jul; 60(1):169-78. PubMed ID: 24519272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mallory-Denk bodies: Correlation with steatosis, severity, zonal distribution, and identification with ubiquitin.
    Kayaçetin S; Başaranoğlu M
    Turk J Gastroenterol; 2015 Nov; 26(6):506-10. PubMed ID: 26507848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermediate filament cytoskeleton of the liver in health and disease.
    Strnad P; Stumptner C; Zatloukal K; Denk H
    Histochem Cell Biol; 2008 Jun; 129(6):735-49. PubMed ID: 18443813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations.
    Salmhofer H; Rainer I; Zatloukal K; Denk H
    Hepatology; 1994 Sep; 20(3):731-40. PubMed ID: 7521318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross β-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions.
    Mahajan V; Klingstedt T; Simon R; Nilsson KP; Thueringer A; Kashofer K; Haybaeck J; Denk H; Abuja PM; Zatloukal K
    Gastroenterology; 2011 Sep; 141(3):1080-1090.e1-7. PubMed ID: 21699779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62.
    Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Hepatology; 2007 Sep; 46(3):851-60. PubMed ID: 17685470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcoholic liver disease: molecular-pathologic aspects.
    Zatloukal K; Kenner L; Preisegger KH; Denk H
    Verh Dtsch Ges Pathol; 1995; 79():28-35. PubMed ID: 8600692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical detection of the 70-kd heat shock protein in alcoholic liver disease.
    Omar R; Pappolla M; Saran B
    Arch Pathol Lab Med; 1990 Jun; 114(6):589-92. PubMed ID: 1693268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the lipogenic pathway in the development of hepatic steatosis.
    Postic C; Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease.
    Vyberg M; Leth P
    APMIS Suppl; 1991; 23():46-52. PubMed ID: 1652996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The keratin cytoskeleton in liver diseases.
    Zatloukal K; Stumptner C; Fuchsbichler A; Fickert P; Lackner C; Trauner M; Denk H
    J Pathol; 2004 Nov; 204(4):367-76. PubMed ID: 15495250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cell culture system for the induction of Mallory bodies: Mallory bodies and aggresomes represent different types of inclusion bodies.
    Hirano K; Guhl B; Roth J; Ziak M
    Histochem Cell Biol; 2009 Sep; 132(3):293-304. PubMed ID: 19381673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From Mallory to Mallory-Denk bodies: what, how and why?
    Zatloukal K; French SW; Stumptner C; Strnad P; Harada M; Toivola DM; Cadrin M; Omary MB
    Exp Cell Res; 2007 Jun; 313(10):2033-49. PubMed ID: 17531973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Toxic memory" via chaperone modification is a potential mechanism for rapid Mallory-Denk body reinduction.
    Strnad P; Tao GZ; So P; Lau K; Schilling J; Wei Y; Liao J; Omary MB
    Hepatology; 2008 Sep; 48(3):931-42. PubMed ID: 18697205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.